SEC Form D · Amendment · filed November 13, 2017
Keros Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Jasbir S. Seehra · Lexington, MAExec · DirectorRan S. Nussbaum · Lexington, MADirectorJulius S. Knowles · Lexington, MADirectorAlon S. Lazarus · Lexington, MADirectorOhad S. Hammer · Lexington, MADirectorFrancisco J. Gonzalez · Miami, FLDirectorDaniel M. Freeman · London, United KingdomDirectorPatricia W. Seminario · Portland, ORDirectorGeoffrey O. Kalish · New York, NYDirectorJuan J. De Abreu Macedo · Miami, FLExec · DirectorEmil W. Henry, Jr · New York, NYDirectorAlessandro M. Boninsegna · New York, NYDirectorRichard J. Trabulsi · New York, NYDirectorKevin M. Morse · Merrillville, INExec · DirectorDean Hatton · Fort Lauderdale, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗